[go: up one dir, main page]

FI873429A7 - Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon. - Google Patents

Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon. Download PDF

Info

Publication number
FI873429A7
FI873429A7 FI873429A FI873429A FI873429A7 FI 873429 A7 FI873429 A7 FI 873429A7 FI 873429 A FI873429 A FI 873429A FI 873429 A FI873429 A FI 873429A FI 873429 A7 FI873429 A7 FI 873429A7
Authority
FI
Finland
Prior art keywords
degenerations
neural
treatment
ophthalmic compositions
ophthalmic
Prior art date
Application number
FI873429A
Other languages
English (en)
Swedish (sv)
Other versions
FI873429A0 (fi
FI873429L (fi
Inventor
George C Y Chiou
Dominic Man-Kit Lam
Rajender Singh Varma
Original Assignee
Houston Biotechnology Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Houston Biotechnology Incorporated filed Critical Houston Biotechnology Incorporated
Publication of FI873429A0 publication Critical patent/FI873429A0/fi
Publication of FI873429A7 publication Critical patent/FI873429A7/fi
Publication of FI873429L publication Critical patent/FI873429L/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI873429A 1986-08-18 1987-08-06 Oftalmologiska kompositioner foer behandling av nervdegenerationer. FI873429L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89774486A 1986-08-18 1986-08-18

Publications (3)

Publication Number Publication Date
FI873429A0 FI873429A0 (fi) 1987-08-06
FI873429A7 true FI873429A7 (fi) 1988-02-19
FI873429L FI873429L (fi) 1988-02-19

Family

ID=25408350

Family Applications (2)

Application Number Title Priority Date Filing Date
FI873429A FI873429L (fi) 1986-08-18 1987-08-06 Oftalmologiska kompositioner foer behandling av nervdegenerationer.
FI873428A FI873428A7 (fi) 1986-08-18 1987-08-06 Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI873428A FI873428A7 (fi) 1986-08-18 1987-08-06 Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon.

Country Status (6)

Country Link
EP (2) EP0265042A3 (fi)
JP (2) JPS6399013A (fi)
KR (2) KR880002519A (fi)
AU (2) AU7671887A (fi)
DK (2) DK427287A (fi)
FI (2) FI873429L (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364884A (en) * 1993-01-21 1994-11-15 Baylor College Of Medicine Arginine compounds as ocular hypotensive agents
GB9326010D0 (en) * 1993-12-21 1994-02-23 Sandoz Ltd Improvements in or relating to organic compounds
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
FR2732896B1 (fr) * 1995-04-11 1997-06-13 Prographarm Lab Forme pharmaceutique transdermique pour l'administration percutanee de l'apomorphine
MXPA01011480A (es) * 1999-05-13 2002-06-04 Unihart Corp Composiciones farmaceuticas que comprenden apocodeina y/o sus derivados.
JP4306213B2 (ja) * 2002-09-30 2009-07-29 宇部興産株式会社 6,7−メチレンジオキシクマリンの製造法
JP4175067B2 (ja) * 2002-09-30 2008-11-05 宇部興産株式会社 アルコキシアクリル酸アリールエステル誘導体、及びその製法
US20050054586A1 (en) * 2003-06-30 2005-03-10 Bartels Stephen P. Treatment of ophthalmic disorders
US8088773B2 (en) 2005-05-12 2012-01-03 The Texas A&M University System Therapeutic compositions and methods
HK1212225A1 (en) 2012-06-11 2016-06-10 Macuclear, Inc. Therapeutic formulation and methods of treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU506714B2 (en) * 1976-07-22 1980-01-24 Fisons Limited Bis benzopyram derivatives
US4189491A (en) * 1976-12-16 1980-02-19 Cuendet Jean Francois Tetrahydrocannabinol in a method of treating glaucoma
US4476140A (en) * 1983-05-16 1984-10-09 Yale University Composition and method for treatment of glaucoma
JPS625970A (ja) * 1985-03-15 1987-01-12 Terumo Corp ピラジン誘導体およびこれを含有する血小板凝集抑制剤

Also Published As

Publication number Publication date
KR880002527A (ko) 1988-05-09
DK427387D0 (da) 1987-08-17
JPS6399013A (ja) 1988-04-30
AU7671887A (en) 1988-02-25
JPS6399010A (ja) 1988-04-30
AU7676087A (en) 1988-02-25
FI873429A0 (fi) 1987-08-06
AU592006B2 (en) 1989-12-21
EP0257887A3 (en) 1990-06-27
EP0257887A2 (en) 1988-03-02
FI873428A0 (fi) 1987-08-06
DK427287A (da) 1988-02-19
FI873428L (fi) 1988-02-19
DK427287D0 (da) 1987-08-17
KR880002519A (ko) 1988-05-09
FI873428A7 (fi) 1988-02-19
EP0265042A3 (en) 1990-01-31
FI873429L (fi) 1988-02-19
EP0265042A2 (en) 1988-04-27
DK427387A (da) 1988-02-19

Similar Documents

Publication Publication Date Title
FI874671A0 (fi) Anordning foer foerhindrande av laeckage i tryckledningar.
OA08581A (en) Treatment of diseases caused by retroviruses.
FI874597L (fi) Rening av lipofiliska proteiner producerade med pichia-jaest.
ES2021040B3 (es) Aspirador-irrigador oftalmico.
FI860032L (fi) Behandling av metaller.
DE3582894D1 (de) Hautbehandlungsmittel.
NO872212L (no) Freseverktoey for trebearbeidning.
DE3787529D1 (de) Strahlmittelbehandlung.
ES508202A0 (es) "procedimiento de tratamiento de vegetales".
DE3767694D1 (de) Vorrichtung zur keratotomie der cornea.
FI873429A7 (fi) Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon.
IT8820388A0 (it) Composizione oftalmologica.
FI873455L (fi) Rengoeringsolja foer kroppen.
DE3781881D1 (de) Metallbehandlung.
NO880292D0 (no) Fremgangsmaate for behandling av humle.
FI870944L (fi) Ytbehandlingsfoerfarande.
FI890810L (fi) Behandling av braennskador.
DE3777800D1 (de) Behandlung der wollstoffe.
ES516605A0 (es) "procedimiento para la produccion o tratamiento de ferrocromo".
NO884635D0 (no) Fremgangsmaate for behandling av most.
DE3787493D1 (de) Lederbehandlungsmittel.
FI880733A0 (fi) Anordning foer uppbaerning av solv- eller rittgarn i en vaevstol.
FI871715L (fi) Foerbaettring av svavelextraktion ur jaernmalm behandlat med oxideringsextraktion.
FI851969A7 (fi) Korkean verenpaineen hoitoon soveltuvia tetrahydronaftalenoleja.
IT8622171A0 (it) Composizioni oftalmiche.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: HOUSTON BIOTECHNOLOGY INCORPORATED